mEmerald-Caveolin-N-10 Citations (3)

Originally described in: Overexpression of caveolin-1 is sufficient to phenocopy the behavior of a disease-associated mutant.
Hanson CA, Drake KR, Baird MA, Han B, Kraft LJ, Davidson MW, Kenworthy AK Traffic. 2013 Jun;14(6):663-77. doi: 10.1111/tra.12066. Epub 2013 Apr 7. PubMed Journal

---

Articles Citing mEmerald-Caveolin-N-10

Articles
Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy. Han B, Copeland CA, Kawano Y, Rosenzweig EB, Austin ED, Shahmirzadi L, Tang S, Raghunathan K, Chung WK, Kenworthy AK. Traffic. 2016 Dec;17(12):1297-1312. doi: 10.1111/tra.12452. Epub 2016 Nov 2. PubMed
A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal. Copeland CA, Han B, Tiwari A, Austin ED, Loyd JE, West JD, Kenworthy AK. Mol Biol Cell. 2017 Nov 1;28(22):3095-3111. doi: 10.1091/mbc.E17-06-0421. Epub 2017 Sep 13. PubMed
JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by beta-Arrestin. Mayberry CL, Soucy AN, Lajoie CR, DuShane JK, Maginnis MS. J Virol. 2019 Apr 3;93(8). pii: JVI.01948-18. doi: 10.1128/JVI.01948-18. Print 2019 Apr 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.